
RIO DE JANEIRO, Jan 15, 2007 (AFP) - Brazilian researchers have developped an algae-based, microbe-killing gel for women aimed at blocking the sexual transmission of HIV.
The microbicide was 95 percent efficient in the first phase of testing over the last three years, the research's coordinator, immunologist Luiz Castello Branco, told Folha de Sao Paulo newspaper.
A second round of tests will start in February on mice and live cells from the cervix, said Branco, a researcher at the Oswaldo Cruz Institute in Rio de Janeiro. Human studies would start in 2008.
"We will certainly get to a final product with an efficiency above 50 percent," he said.
The gel -- based on a substance taken from Dictyota pfaffi, a type of algae found on the Brazilian coast -- could be put on the market in seven years, he said.
"A woman could use the gel without the husband knowing," Branco said.
"Right now we will test the product's safety and the ideal dose," said Branco, whose team is working with researchers from Fluminense Federal University and Ataulpho de Paiva Foundation.
070115
AF070110
Copyright ©AFP 2007. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission obtained from the owners of any trademarks or copyrighted materials whose marks and materials are included in AFP photos or materials. Therefore you will be solely responsible for obtaining any and all necessary releases from whatever individuals and/or entities necessary for any uses of AFP stories, photos or graphics. http://www.afp.com/
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, John M. Lloyd Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.